| pharmaceutical patents | ||
| NEWS | ||
| Allergan seeks tribe's help in patent dispute In a novel arrangement, the pharmaceutical maker Allergan has enlisted the ... Allergan retains exclusive licenses to the patents until they end in 2024. | ||
| Patent battle over generic Inomax leaves five Mallinckrodt patents invalid as naturally occurring ... On Tuesday, September 5th, the patent portfolio of UK-based pharmaceutical firm Mallinckrodt PLC (NYSE:MNK) suffered a large setback after a ... |
Patent Trademark copyright and design blogs
Monday, September 18, 2017
pharmaceutical patents
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment